Oil and gas prices soared while gold and other metals crumbled, impacting ASX 200 shares in different ways.

Shares in the energy sector surged 18.5% while the materials sector, which includes Australia's biggest miners, crumbled 14.1%.

Amid the upheaval for share prices, brokers reviewed their ratings and 12-month targets on a bunch of ASX stocks.

Here are some of the ASX 200 shares elevated to strong buy consensus status after last month's turmoil.

7 ASX 200 shares newly elevated to strong buy ratings

These ASX shares have just been upgraded to strong buy consensus ratings on the CommSec platform.

A consensus rating represents the average rating among analysts.

Genesis Minerals Ltd (ASX: GMD)

The Genesis Minerals share price dropped 20.7% in March alongside a steep fall in the gold price.

So far this month, the ASX 200 gold mining share is up 10.9% to $6.53 at yesterday's close.

MA Financial is among the brokers that have upgraded Genesis Minerals to a buy rating.

The broker has lifted its 12-month price target from $8.05 to $8.40.

Orica Ltd (ASX: ORI)

The Orica share price descended 17.9% in March.

So far this month, the ASX materials share is up 6.7% to $21.40.

Jefferies has reiterated its buy recommendation, but reduced its price target from $25.73 to $24.04.

Qantas Airways Ltd (ASX: QAN)

The Qantas share price fell 15.9% in March.

So far in April, the ASX 200 airline share has rebounded 8.6% to $9.09.

Jefferies has reiterated its buy rating with a price target of $12.80.

WiseTech Global Ltd (ASX: WTC)

The WiseTech Global share price declined 20% in March.

So far in April, the market's largest ASX 200 tech share is up just 1.6% to $38.62.

Morgan Stanley is buy-rated on Wisetech but has slashed its target from $100 to $70.

Xero Ltd (ASX: XRO)

The Xero share price descended 9.7% in March.

The tech share has fallen a further 2.3% in April to $73.41 at yesterday's close.

Morgan Stanley has reiterated its buy recommendation with a $130 target.

Yancoal Australia Ltd (ASX: YAL)

The Yancoal share price skyrocketed 41.5% in March, as power plants switched from gas to coal.

So far this month, the ASX 200 coal share has declined 10.3%.

Huatai Securities is buy-rated on Yancoal with a $14.40 share price target.

CAR Group Ltd (ASX: CAR)

The CAR Group share price fell 14% in March.

In April, the ASX 200 retail share is up 2.7% to $23.41.

Morgan Stanley reiterated its buy recommendation last week.

However, the broker reduced its 12-month target from $38 to $32.

The post 7 ASX 200 shares just upgraded to strong buy ratings appeared first on The Motley Fool Australia.

The three S&P/ASX 200 Index (ASX: XJO) shares I'm about to note are among the leaders in the world at what they do, and analysts think they have the potential to deliver large capital gains in the long term.

Let's have a look at what they do and how excited analysts are.

Aristocrat Leisure Ltd (ASX: ALL)

Aristocrat is a major player in the global poker machine and casino management system space. It also has a sizeable mobile game segment.

According to CMC Invest, there have been 9 analyst ratings on the business over the last 3 months, all of which were buy ratings.

The average price target – where analysts think the business will be trading in a year from now – is $67.06. At the time of writing, that suggests a rise of more than 40%.

The most optimistic price target is $73.71, suggesting a possible rise of more than 50%, while the lowest price target is $62.75, implying a suggested rise of more than 30%.

According to the projection on CMC Invest, the ASX share is valued at around 18x FY26's estimated earnings.

Orica Ltd (ASX: ORI)

The next ASX share I'll highlight is Orica, which describes itself as a global leader in mining and infrastructure services, explosives manufacturing, digital solutions, and specialty mining chemicals.

According to CMC Invest, there have been 11 recent ratings on the business – all of them were a buy.

The average price target on CMC Invest of $26.08 suggests a possible rise of around 25% at the time of writing, while the highest estimate of $29.88 implies a rise of well over 40%. However, the lowest price target of $23.95 suggests only a 15% potential rise.

Using the earnings forecast on CMC Invest, the business is valued at 17x FY26's estimated earnings.

Xero Ltd (ASX: XRO)

Xero is one of the world's leading cloud accounting and payments businesses.

According to CMC Invest, of the seven recent ratings on the ASX tech share, six were buy.

Impressively, the average price target of those ratings is $157.28, suggesting a possible increase of around 100%. The highest price target is $232.88, suggesting it could rise around 200%. That may be a bit ambitious for 2026.

But, not everyone is so confident – the lowest price target is $82.37. That suggests a rise of less than 10% from where it is today.

Based on broker UBS' projections, the business is valued at 67x FY26's estimated earnings.

The post Brokers rate these 3 top ASX shares as buys in April appeared first on The Motley Fool Australia.

Despite several stints in green territory this morning, the ASX 200 ended up closing in the red by the time trading wrapped up this afternoon, dropping 0.1%. That leaves the index at 8,525.7 points.

This miserly day for Australian investors follows a far more optimistic morning on Wall Street.

The Dow Jones Industrial Average Index (DJX: .DJI) was in fine form, rising by 0.66%.

The tech-heavy Nasdaq Composite Index (NASDAQ: .IXIC) did even better, gaining a rosy 0.77%.

But time to return to the local markets now and see how today's falls were distributed amongst the different ASX sectors today.

The post Here are the top 10 ASX 200 shares today appeared first on The Motley Fool Australia.

Three ASX shares that brokers have named as buys this week are listed below. Here's why their analysts are feeling bullish on them right now:

Orica Ltd (ASX: ORI)

According to a note out of Morgans, its analysts have retained their buy rating on this commercial explosives company's shares with an improved price target of $25.35. This follows the release of a stronger than expected trading update earlier this week. In addition, the broker was pleased to see that Orica has settled its litigation in the United States and announced an acquisition in the country. Morgans believes that the latter will strengthen its US operations. Outside this, Morgans highlights that the company has leverage to attractive industry fundamentals, market leading positions, solid earnings growth, proven management team, and a strong balance sheet. The Orica share price is trading at $20.02 on Wednesday afternoon.

Perseus Mining Ltd (ASX: PRU)

A note out of Ord Minnett reveals that its analysts have upgraded this gold miner's shares to a buy rating with an increased price target of $6.80. The broker made the move after Perseus Mining announced the sale of its Meyas Sand gold project in Sudan. Ord Minnett was pleased with the price that the company has received, especially given the difficulties operating in a country experiencing a civil war. Overall, it sees Perseus Mining as one of the best ways to gain exposure to the African gold industry and feels that the sale of the Meyas Sand gold project strengthens the quality of its portfolio. The Perseus Mining share price is fetching $5.19 at the time of writing.

Xero Ltd (ASX: XRO)

Analysts at Citi have retained their buy rating and $144.80 price target on this cloud accounting platform provider's shares. According to the note, the broker believes that macro trends are positive for Xero. It highlights that business formation is accelerating in both Australia and the United States, while insolvency trends are improving. This combination points to positive demand for its platform according to the broker. Coupled with potential margin expansion from cost efficiencies and AI adoption, Citi believes Xero is well-placed to grow its earnings. The Xero share price is trading at $79.66 on Wednesday.

The post Top brokers name 3 ASX shares to buy today appeared first on The Motley Fool Australia.

Let's see what they are saying about the three named below, which have released updates in recent days. Here's what you need to know:

Clarity Pharmaceuticals Ltd (ASX: CU6)

Bell Potter has been pleased with recent study data relating to this radiopharmaceutical company's 64Cu-SAR-bis-PSMA PET product. It highlights that it is significantly outperforming Ga-PSMA-11 PET in the detection of biochemical recurrence in men with very low PSA levels.

As a result, the broker has reaffirmed its speculative buy rating and $6.40 price target on its shares. It said:

The stage is now set for a readout from the approval study for 64Cu-SAR-bisPSMA (AMPLIFY) which has now ceased accepting new patient consents and is practically fully enrolled (n=220). The Co-PSMA data along with data from COBRA and anticipated findings from AMPLIFY will form the basis of submission of a new drug application to be submitted to the FDA.

CU6 has three fast track designations for the SAR-bisPSMA agent which includes patients with BCR of prostate cancer following definitive therapy. The company is well funded with cash in excess of $226m at 31 Dec 2025.

New Hope Corporation Ltd (ASX: NHC)

This coal miner disappointed analysts at Morgans with its half-year results. The broker highlights that its net profits were much softer than expected.

In light of this, the broker has retained its hold rating with a $5.00 price target. It said:

Overall result missed expectations, with underlying NPAT of A$54m materially below MorgansF (A$63m) and Visible Alpha consensus (A$78m), despite EBITDA of A$215m coming in line with expectations. NHC declared a fully franked 10c dividend, beating MorgansF (8c) and consensus (6c) estimates.

With an increasing production profile and material upside potential in coal prices, NHCs outlook remains positive. We maintain a HOLD rating with a target price of A$5.00ps.

Orica Ltd (ASX: ORI)

Morgans was pleased with this commercial explosives and blasting systems company's trading update.

It was also pleased to see its CF Industries litigation settled and the strengthening of its US operations with an acquisition.

This has seen Morgans reiterate its buy rating with an improved price target of $25.35. It said:

ORI's trading update was slightly stronger than we expected. It also announced the settlement of its litigation with CF Industries and the acquisition of its US explosives JV partner, Nelson Brothers, strengthening its US operations. Higher AUD and Indonesia's coal production quotas have seen us make minor revisions to our FY26 forecasts but the acquisition has upgraded FY27/28.

With leverage to attractive industry fundamentals, market leading positions, solid earnings growth, proven management team and strong balance sheet, we reiterate our BUY rating with a new price target of A$25.35.

The post Buy, hold, sell: Clarity Pharmaceuticals, New Hope, and Orica shares appeared first on The Motley Fool Australia.

Macquarie has had a look at the impacts of this and still retains a bullish price target on the stock, but we'll get to that later.

Firstly, let's look at what Orica announced this week.

Simplifying the business

The major chemicals and explosives company said it had settled litigation with CF Industries for US$169.5 million, "following careful consideration of the best interests of shareholders and customers''.

The company said the settlement removes litigation uncertainty and also allows it to establish a new, diversified supply base in the US.

The settlement will be funded from existing cash and undrawn bank debt facilities.

Orica also reached an agreement with its joint venture partner, Nelson Brothers, to acquire its explosives business for US$25 million, plus the retirement of US$48 million in debt.

Orica said it expected the combination of the legal settlement and the company acquisition to be earnings per share accretive in the first full financial year of ownership, and that the US business would be simplified, with growth potential and greater operational resilience.

The acquisition is expected to boost EBIT by about $35 million per year once fully integrated, "with further opportunities to grow revenue and realise additional business cost synergies''.

Orica Managing Director Sanjeev Gandhi said:

Orica has agreed to settle this litigation with CF following careful consideration and in the best interests of shareholders and customers. Our focus remains on executing our strategy, advancing our growth initiatives and delivering sustainable value for customers and shareholders. Importantly, our actions have ensured there has been no disruption to customer supply, and we remain committed to strengthening security of supply for our customers through a diversified and resilient sourcing strategy in North America. The combination of the settlement and the acquisition of Nelson Brothers' US Explosives business will further strengthen our North American region, deliver immediate earnings benefits and support our strategy to grow in attractive downstream markets.

Orica shares looking cheap

The Macquarie team ran the ruler over this week's transactions and said the settlement removed litigation overhang, estimating that legal action had cost the company $100 million over the past two years.

Macquarie has reduced its price target on Orica shares slightly from $25.50 to $25.40 on minor earnings per share changes; this is still well above the current share price of $19.63.

If achieved, the Macquarie price target would constitute a 29.4% gain, and Orica is also expected to pay a 3.2% dividend yield.

Orica was valued at $8.99 billion at the close of trade on Monday.  

The post How high does Macquarie think Orica shares will go? appeared first on The Motley Fool Australia.

At the time of writing, the ASX 200 industrial stock is down over 2% to $19.23.

Why are Orica shares falling today?

The catalyst for the move appears to be news that Orica has reached a settlement in a long-running legal dispute in the United States and has agreed to make an acquisition.

According to the release, Orica has settled litigation with CF Industries (NYSE: CF) for a payment of US$169.5 million (A$242.3 million). The dispute began in October 2023 and the settlement has been reached with no admission of liability by any party.

Management said the agreement removes litigation uncertainty and will allow the company to establish a more diversified supply base for its US operations, strengthening security of supply for customers in the region.

The payment will be made in the second half of FY 2026 and funded using Orica's existing cash and undrawn committed bank debt facilities.

ASX 200 stock announces US acquisition

Alongside the settlement, Orica revealed that it has agreed to acquire 100% of the explosives business of Nelson Brothers, its current joint venture partner in the United States.

The deal will see the ASX 200 stock purchase the outstanding membership interests in Nelson Brothers LLC and Nelson Brothers Mining Services. Under the agreement, Orica will pay US$25 million and retire US$48 million of existing debt associated with the explosives business.

The acquisition will provide Orica with four emulsion plants, initiating system magazines located in key markets, and mobile manufacturing unit bulk explosives delivery vehicles. It will also increase storage capacity and provide direct channels to market in the US quarries and construction sectors.

Management expects the transaction to close in the second half of FY2026, subject to due diligence and final agreements.

Commenting on both developments, the ASX 200 stock's managing director and CEO, Sanjeev Gandhi, said:

Orica has agreed to settle this litigation with CF following careful consideration and in the best interests of shareholders and customers. Our focus remains on executing our strategy, advancing our growth initiatives and delivering sustainable value for customers and shareholders. Importantly, our actions have ensured there has been no disruption to customer supply, and we remain committed to strengthening security of supply for our customers through a diversified and resilient sourcing strategy in North America.

The combination of the settlement and the acquisition of Nelson Brothers' US Explosives business will further strengthen our North American region, deliver immediate earnings benefits and support our strategy to grow in attractive downstream markets.

The post Guess which ASX 200 stock has settled a major US litigation and made an acquisition appeared first on The Motley Fool Australia.

What did Orica report?

• Settled litigation with CF Industries for US$169.5 million, funded from existing cash and undrawn debt facilities
• Agreement to acquire Nelson Brothers' US explosives business for US$25 million plus retirement of US$48 million in debt
• Transactions expected to be earnings per share (EPS) accretive in the first full financial year
• Acquisition to boost EBIT by AUD$35 million per year once fully integrated
• Increased exposure to the strategic North American market, especially US Quarries and Construction sectors

What else do investors need to know?

Orica's settlement with CF Industries brings an end to litigation that began in October 2023, with no admission of liability by either party. This move removes a significant source of uncertainty for Orica's shareholders and customers.

The acquisition of Nelson Brothers' explosives business will give Orica full ownership of four US emulsion plants and wider access to downstream markets. The deal also expands Orica's exposure in critical end markets through improved supply chain and delivery capabilities, plus enhanced opportunities for cross-selling its product and service offerings.

What did Orica management say?

Orica Managing Director and CEO Sanjeev Gandhi said:

Orica has agreed to settle this litigation with CF following careful consideration and in the best interests of shareholders and customers. Our focus remains on executing our strategy, advancing our growth initiatives and delivering sustainable value for customers and shareholders.

Importantly, our actions have ensured there has been no disruption to customer supply, and we remain committed to strengthening security of supply for our customers through a diversified and resilient sourcing strategy in North America.

The combination of the settlement and the acquisition of Nelson Brothers' US Explosives business will further strengthen our North American region, deliver immediate earnings benefits and support our strategy to grow in attractive downstream markets.

What's next for Orica?

Looking ahead, Orica expects the combination of the litigation settlement and new acquisition to simplify its business structure and create greater operational resilience. Management sees upside through increased presence in the attractive North American market, as well as potential revenue growth and business synergies from the Nelson Brothers acquisition.

The integration of the newly acquired business and a move to diversify Orica's ammonium nitrate supply are aimed at supporting sustainable long-term growth and further protecting customer supply chains.

Orica share price snapshot

Over the past 12 months, Orica shares have risen 11%, slightly outperforming the S&P/ASX 200 Index (ASX: XJO) which has risen 10% over the same period.

View Original Announcement

The post Orica settles US litigation and announces US acquisition appeared first on The Motley Fool Australia.

When experts call a business a buy, it's worth taking note because of the positive outlook that the analysts have identified for the business(es).

The two stocks I'm going to highlight are both from outside the tech industry. Accordingly, they could have clearer growth outlooks than others because they're not as exposed to possible AI impacts. Let's take a look at why the ASX shares are buy-rated by UBS.

GQG Partners Inc (ASX: GQG)

UBS describes GQG as a boutique active asset manager that specialises in managing global shares. The business has a track record of strong performance over most of its life and it also provides funds for a relatively low cost.

The broker said that the month of February 2026 saw a record high funds under management (FUM) which was a 4.3% month-over-month increase, driven by investment returns. However, it continued to experience elevated net outflows of US$3.2 billion, though lower than UBS was expecting of US$3.7 billion.

There was an improvement in US equity outflows, with that strategy experiencing a sharp improvement in performance in US equities flows. This suggests that this rebound could lead to a relatively quick turnaround in outflows.

However, the emerging market strategy, where underperformance has been deepest, continues to be a headwind with outflows for the ASX share.

Pleasingly, early March has seen outperformance by GQG's strategies. UBS then explained why it rates GQG as a buy with a price target of $2:

We continue to see GQG as an attractive market-hedge, and a relative performance beneficiary of the current backdrop given its defensive portfolio tilts.

Orica Ltd (ASX: ORI)

UBS describes Orica as the world's largest supplier of commercial explosives and blasting systems servicing both the mining and infrastructure sectors. The broker also noted that the business manufactures ammonium nitrate (AN) from its plants in Australia, North America and Indonesia.

UBS recently released a note highlighting that the ASX share released a trading update which included expectations that the FY26 first half operating profit (EBIT) will be slightly higher than the prior corresponding period of A$493 million. That expectation is "broadly consistent" with the average forecast of market analysts (consensus) of A$493 million.

However, Orica expects blasting solutions EBIT to be lower year over year because of foreign exchange rates and lower Indonesian coal demand. Digital solutions and specialty mining chemicals are supposedly on track to deliver EBIT growth of 20% and 15%, respectively, year-over-year thanks to strong gold and copper exploration and production demand.

UBS is forecasting that Orica's FY26 EBIT could grow by 2% despite the foreign exchange and Indonesian demand headwinds. The broker said:

We retain our Buy rating with the stock offering a 3yr EPS CAGR of 8% (FY25-28E) linked to resilient global mine production activity, and supportive AN prices given potentially tightening global supply. UBS rates Orica as a buy with a price target of $27.

The post 2 compelling ASX shares experts rate as buys in March appeared first on The Motley Fool Australia.

That's because the broker has just put a buy rating on one ASX 200 share.

Which ASX 200 share?

The company that Bell Potter is bullish on is Orica Ltd (ASX: ORI).

It is a leading solution provider to the global mining and infrastructure markets. Its solutions include the manufacture and supply of explosives, blasting systems, and speciality mining chemicals. In addition, it offers the provision of orebody intelligence, geotechnical, and structural monitoring products and services.

Bell Potter highlights that the ASX 200 share released a business update this week, which was largely in line with expectations. It said:

ORI has provided a 1H FY26 business update, outlining positive group momentum continuing into FY26TD, with 1H FY26 group uEBIT expected to be "slightly higher" than the PcP (BPe +3.0%). Key points: Blasting Solutions: uEBIT to be slightly below the PcP (BPe -1.3%), due to a higher AUD:USD and lower Indonesian coal production quotas. These headwinds were partially offset by strong demand for premium products and advanced blasting technologies, continued commercial discipline and robust network performance.

Digital Solutions: uEBIT is forecast to increase by ~20% vs the PcP (BPe +24.0%), underpinned by increasing adoption of digital offerings and recurring revenue growth, strong metals exploration activity and increased cross-selling across the portfolio. Speciality Mining Chemicals: uEBIT is anticipated to lift ~15% vs the PcP (BPe +27.2%), supported by strong demand for sodium cyanide from gold customers

Should you invest?

In response to the update, Bell Potter has retained its buy rating and $28.50 price target on the ASX 200 share.

Based on its current share price of $20.92, this implies potential upside of 36% for investors over the next 12 months.

In addition, a 3.1% dividend yield is expected in 2026, which takes the total potential return to over 39%.

Bell Potter likes the company due to its belief that it is well-placed to benefit from cyclical tailwinds across its target markets. The broker explains:

ORI is well positioned to capitalise on improving short-to-medium term cyclical tailwinds across mining production, exploration and gold processing markets. Notwithstanding these tailwinds, we express caution regarding input cost and supply.

The post Buy this ASX 200 share benefiting from 'cyclical tailwinds': Top broker appeared first on The Motley Fool Australia.

At the time of writing, the leading mining and infrastructure solutions provider's shares are up 2.5% to $22.18.

Why is this ASX 200 share rising?

Investors have been buying Orica's shares following the release of a positive first-half business update and the announcement of a new cost reduction program.

According to the release, the strong momentum seen in its business during FY 2025 has continued into the first five months of FY 2026.

As a result, the ASX 200 share expects first-half earnings before interest and tax (EBIT) to be slightly higher than the prior corresponding period.

Management advised that this performance reflects strong demand for its premium blasting products and advanced blasting technologies, as well as consistent operational performance across its global manufacturing network.

However, some headwinds remain. A stronger Australian dollar and lower Indonesian coal production quotas are expected to weigh slightly on earnings from the Blasting Solutions division.

Digital and chemicals divisions performing strongly

The ASX 200 share highlighted particularly strong growth in its Digital Solutions business.

Orica said increasing adoption of its digital offerings and recurring revenue growth are expected to drive an approximately 20% increase in EBIT for this segment compared with the prior period.

Meanwhile, its Specialty Mining Chemicals division is also performing well, supported by strong demand for sodium cyanide in the gold mining sector. Following upgrades to its Winnemucca production facility in the United States, Orica expects EBIT for this segment to rise by around 15% year on year.

$100 million cost reduction program

Alongside the trading update, Orica also announced a new organisation-wide program aimed at reducing its cost base. The initiative is expected to deliver at least $100 million in annualised cost savings over the next three years.

Management said the program is designed to position the ASX 200 share for the next phase of sustained profitable growth.

Orica managing director and CEO, Sanjeev Gandhi, said:

I am pleased with the strong start to the underlying business in the 2026 financial year. Our performance reflects the resilience of our business, and the strength of our integrated offering, operational reliability across our global manufacturing network and the ongoing adoption of our premium products, digital solutions and value-added services.

Despite a more volatile operating environment and increasing geopolitical complexity, we have continued to support customers by leveraging our global footprint, maintaining continuity of supply and focusing on operational excellence. Whilst market conditions remain dynamic, we're confident in the strong fundamentals of our business and our ability to continue to execute our strategy. We remain focused on disciplined capital management and rebasing our costs while advancing our growth initiatives and delivering sustainable value for customers and shareholders.

The post Guess which ASX 200 share is storming higher on business update appeared first on The Motley Fool Australia.

To narrow things down, let's see what analysts are saying about three popular shares, courtesy of The Bull. Here's what they are recommending:

Orica Ltd (ASX: ORI)

The team at Bell Potter is bullish on this commercial explosives company and has named it as a buy this week.

The broker has been impressed with its transformation and highlights its cyclical leverage and structural growth as reasons to invest. It explains:

Orica is a mining and infrastructure solutions provider. Orica's transformation is gaining traction, with diversified growth across blasting solutions, speciality mining chemicals and digital solutions. Earnings before interest and tax (EBIT) of $992 million in fiscal year 2025 were up 23 per cent on the prior corresponding period. The significant rise was underpinned by strong demand for sodium cyanide, increased digital product uptake and solid execution across manufacturing assets. Management has upgraded its medium term EBIT target, and an additional $100 million buy-back program is underway. Orica offers a compelling blend of cyclical leverage and structural growth.

Origin Energy Ltd (ASX: ORG)

Over at DP Wealth Advisory, its team has named this energy giant as a hold this week.

While it sees positives, such as its investment in Octopus Energy, it isn't enough for a more bullish recommendation. DP Wealth Advisory said:

This energy provider delivers services to more than 4 million Australian customers. It's also a significant exporter of LNG through its stake in APLNG (Australia Pacific LNG). A positive for Origin is its 22.7 per cent interest in Octopus Energy in the UK and, in particular, the Kraken Technologies platform. A spin-off of Kraken into a stand-alone entity should add value to ORG.

Pro Medicus Ltd (ASX: PME)

Analysts at Fairmont Equities aren't buyers of this health imaging technology company's shares despite their heavy decline. The equities firm has named Pro Medicus shares as a sell this week.

Fairmont Equities appears concerned that the decline could continue if sentiment doesn't improve in the near term. It said:

This medical technology business is one we have successfully traded on several occasions during the past few years. However, since mid-2025, we have stayed away from expensive technology companies, such as PME, due to negative market sentiment. On February 12, 2026, the company announced revenue from ordinary activities of $124.8 million in the first half of 2026, an increase of 28.4 per cent. Underlying net profit of $67.3 million was up 29.7 per cent.

However the share price was severely punished following the result. Perhaps, the result fell short of market expectations. The shares have fallen from $330.48 on July 17, 2025 to trade at  $132.86 on February 12, 2026. The shares may fall further if sentiment doesn't improve.

The post Buy, hold, sell: Orica, Origin Energy, and Pro Medicus shares appeared first on The Motley Fool Australia.

Three ASX shares that have fared well and are being recommended by the broker to its clients are named below.

Here's why the broker is bullish on these names:

Dexus Convenience Retail REIT (ASX: DXC)

Bell Potter believes that Dexus Convenience Retail REIT offers a compelling mix of defensive income and valuation support.

The broker highlights DXC's high-quality portfolio of service stations and convenience retail assets, leased to long-term, non-discretionary tenants. This includes tenants such as 7-Eleven, Ampol (ASX: ALD), and Chevron. This provides stable cash flows and resilience through the cycle.

Importantly, Bell Potter sees scope for valuation upside as capitalisation rates stabilise. It said:

Petrol stations are typically a low volatility asset class given long term leases with strong covenants, however higher debt base rates are likely to see cap rate expansion ahead. Asset valuations however at a 6.3% portfolio cap rate do not look demanding to us vs. industry transactions and peer REITs.

Bell Potter has a buy rating and price target of $3.25 on Dexus Convenience Retail REIT's shares. Based on its current share price of $2.82, this implies upside of more than 15%. That's before factoring in a forecast dividend yield of around 7.5%.

Orica Ltd (ASX: ORI)

Orica is an ASX share to buy this week according to Bell Potter.

The broker points to strong structural tailwinds driven by increased production of iron ore, copper, and gold, which should underpin long-term demand for blasting services. It notes that Orica's scale, global footprint, and pricing discipline position it well to benefit from this trend. The broker said:

We expect EBIT growth momentum to be sustained in the short-to-medium term underpinned by cyclical tailwinds in mining and exploration markets. EBIT growth is expected to be supported by further premium product uptake, robust facility performance across AN and sodium cyanide supply networks and commercial discipline.

Bell Potter has put a buy rating and $28.50 price target on Orica shares. Based on its current share price of $25.38, this implies potential upside of 12% for investors.

Sonic Healthcare Ltd (ASX: SHL)

Finally, Bell Potter believes Sonic Healthcare offers an appealing combination of income and share price upside.

The broker expects Sonic to return to double-digit earnings growth in FY 2026, driven largely by acquisitions, particularly in pathology, and steady demand across its diagnostics businesses. While cost control and execution remain key risks, Bell Potter believes much of this is already reflected in the share price. It said:

While SHL has outperformed the XHJ, it has materially underperformed the broader market, reflecting concerns with growth and cost control. If the new CEO can impress investors with financial performance and strategy, we believe upside remains in SHL.

Bell Potter has a buy rating and $28.50 price target on Sonic Healthcare's shares. Based on its current share price of $21.82, this suggests that upside of 30% is possible. In addition, the broker is forecasting a dividend yield of approximately 5% in FY 2026.

The post Broker names 3 ASX shares to buy this week appeared first on The Motley Fool Australia.

The company is a leading global manufacturer and supplier of explosives and blasting systems, primarily to the mining industry. 

It is the world's number one supplier of commercial explosives with operations across more than 100 countries and an approximate market share of around 28%.

Its share price has risen by 50% in the last 12 months. 

This helped it qualify as one of the 10 best ASX 200 large-cap shares of 2025. 

For context, the S&P/ASX 200 Index (ASX: XJO) is up 4.5% in that same period. 

It seems there could be more growth ahead for this ASX materials stock. 

A new report from Bell Potter released yesterday included a price target increase, along with an unchanged buy recommendation. 

Here is what the broker had to say. 

Market dynamics still favourable 

According to yesterday's report, mining activity across the company's two largest Blasting Solutions geographies (Australia Pacific & Asia and North America) continue to exhibit positive momentum in FY26TD.

Bell Potter said in Australia, the iron ore majors delivered record production in the Dec' 25 quarter. 

In addition, the rapid appreciation of spodumene concentrate prices has prompted producers to assess plans to reactivate idled production capacity. 

Looking ahead, the Australian government projects iron ore and gold production CAGR of 3% and 12% over FY25-27, respectively.

Based on estimates, mining-related activity in North America was about 5% higher in Oct – Nov 2025 compared to Oct – Nov 2024.

In Canada, production of copper concentrate, gold and coal grew 13%, 8% and 1% YoY in Oct-Nov'25.

In summary, Bell Potter believes this ASX materials stock is benefiting from strong momentum across global mining and exploration.

This is being driven by rising production, higher commodity prices, and surging exploration funding – supporting confidence in higher activity levels and making the upgraded mid-teens Digital Solutions EBIT growth target achievable.

Target price rises for the ASX materials stock

Based on this guidance, Bell Potter lifted its price target to $28.50 from $26.00, while EPS forecasts remain unchanged.

The broker retained its buy recommendation. 

From yesterday's closing price of $26.03, this indicates an approximate upside of 9.49%. 

The broker said EBIT growth is expected to continue on the back of strong mining and exploration conditions, solid operations and product mix. 

We expect EBIT growth momentum to be sustained in the short-to-medium term underpinned by cyclical tailwinds in mining and exploration markets. EBIT growth is expected to be supported by further premium product uptake, robust facility performance across AN and sodium cyanide supply networks and commercial discipline.

The post Is this ASX materials stock still a buy after rising 50% in the last year? appeared first on The Motley Fool Australia.

Here, we look at the 10 best ASX 200 large-cap shares of 2025 for capital growth.

Large caps have a market capitalisation of $10 billion or more. All the stocks below fit this category.

Investors like large caps because they are typically older, well-established companies that pay reliable dividends every year.

Let's check out last year's best performers.

10 best ASX 200 large caps for share price growth

1. Evolution Mining Ltd (ASX: EVN)

The Evolution Mining share price rose by 164% to close the year at $12.68 apiece.

ASX gold shares had a fantastic year due to a 65% rally in the gold price on top of a 27% gain in 2024.

The gold price rose to a new record of US$4,533 per ounce in December.

Evolution Mining shares are $12.92 apiece on Thursday, down 0.6%.

2. Newmont Corporation CDI (ASX: NEM)

Newmont Corporation shares increased 152% to finish 2025 at $150.20 apiece.

The ASX gold share continues to streak higher, hitting a new 52-week peak of $162.45 yesterday.

The Newmont share price is $158.66 today, up 0.1%.

3. Lynas Rare Earths Ltd (ASX: LYC)

The Lynas Rare Earths share price rose by 93.5% to $12.44 on 31 December.

Today, the ASX 200 large-cap rare earths share is trading at $14.74, down 2.2%.

Lynas shares were the market's best performer yesterday amid improving sentiment about rare earths prices.

4. PLS Group Ltd (ASX: PLS)

Formerly known as Pilbara Minerals, PLS Group shares lifted 93% to close the year at $4.22.

The ASX 200 large-cap lithium share set a new 52-week high of $4.89 today.

5. Northern Star Resources Ltd (ASX: NST)

The share price of the ASX 200's largest gold miner rose 73% to close the year at $26.73.

The ASX gold share has fallen in the first week of 2026 to $24.88 today.

An operational update released on 2 January prompted some investors to sell.

6. Charter Hall Group (ASX: CHC)

Shares in this property fund manager ripped 71% higher to close out the year at $24.45.

The ASX 200 large-cap real estate investment trust (REIT) is steady at $24.07 today.

7. Mineral Resources Ltd (ASX: MIN)

This ASX 200 large-cap mining share had a turbulent year due to governance issues and other factors.

The Mineral Resources share price plunged to a 52-week low of $14.05 before commencing a recovery.

Mineral Resource shares managed a 59% gain over the year to close at $54.38 apiece on 31 December.

The Mineral Resources share price is $57.91 on Thursday, up 1.1%.

8. Orica Ltd (ASX: ORI)

Shares in the explosives manufacturer rose 46% to $24.28 in 2025.

Today, Orica shares are trading at $25.85 apiece, down 0.1%.

9. ALS Ltd (ASX: ALQ) 

The ALS share price rose 46% to $22.04 last year.

ALS provides testing solutions to clients in a wide range of industries around the world.

Today, the ALS share price is $22.79, up 2%.

10. Bluescope Steel Ltd (ASX: BSL) 

The Bluescope share price lifted 29% to finish the year at $24.07.

The steel maker is in the news this week after rejecting a takeover offer at $30 per share.

A consortium comprising SGH Ltd (ASX: SGH) and Steel Dynamics, Inc (NASDAQ: STLD) made the offer.

Today, Bluescope shares are $29.31, down 1.9%.

The post 10 best ASX 200 large-cap shares of 2025 appeared first on The Motley Fool Australia.

Here are some ASX All Ords shares that attracted strong buy consensus ratings on the CommSec platform this month.

9 ASX All Ords shares with strong buy ratings for 2026

A consensus rating is the average rating from all analysts covering a stock.

Vault Minerals Ltd (ASX: VAU)

The Vault Minerals share price is currently $5.47, up 1% on Wednesday.

The ASX All Ords gold share has risen 154% in 2025.

Like all ASX All Ords gold stocks, Vault Minerals has benefited from the runaway gold price.

The yellow metal has ripped 66% higher in 2025 and is currently trading at US$4,354 per ounce.

UBS is among the brokers giving Vault Minerals shares a buy rating.

The broker's 12-month price target is $6.60.

Orica Ltd (ASX: ORI) 

The Orica share price is $24.34, down 0.5% on Wednesday.

The explosives manufacturer has experienced 47% share price growth in 2025.

RBC Capital Markets is one of the brokers giving this stock an outperform rating.

Its 12-month price target for Orica shares is $27.50.

Qantas Airways Ltd (ASX: QAN) 

The Qantas share price is $10.30, down 0.1%.

The market's largest ASX All Ords airline share has lifted 13% in 2025.

Here are the important dates for Qantas shareholders in the new year.

NextDC Ltd (ASX: NXT)

The NextDC share price is $12.45 on Wednesday, down 0.2%.

This ASX All Ords technology share is down 17% for 2025.

Jefferies is among the brokers backing NextDC shares for growth in 2026.

The broker's 12-month price target is $18.10.

Westgold Resources Ltd (ASX: WGX) 

The Westgold Resources share price is $6.41, up 0.5% today.

The ASX All Ords gold share has lifted 122% in 2025.

RBC Capital Markets is among the experts giving this stock a buy rating.

The broker lifted its 12-month price target from $5.80 to $7.80 this month.

Wisetech Global Ltd (ASX: WTC)

The Wisetech share price is $68.21, up 0.6% on Wednesday.

The tech sector's No.1 stock by market capitalisation has had a turbulent year.

Overall, Wisetech shares are down 45% in the year to date.

Adore Beauty Group Ltd (ASX: ABY)

Adore Beauty shares are trading at $1.24 apiece, up 2% on Wednesday.

The ASX All Ords consumer discretionary share has ripped 32% in 2025.

Cleanaway Waste Management Ltd (ASX: CWY)

The Cleanaway Waste Management share price is $2.62, up 0.2%.

The ASX All Ords industrial share is down 1% in the year to date.

Goldman Sachs is buy-rated on this stock with a price target of $3.15.

Silex Systems Ltd (ASX: SLX)

The Silex Systems share price is $8.51, up 2.4% today.

The ASX All Ords industrials share is up 67% for 2025.

The nuclear technology developer ascended into the S&P/ASX 200 Index (ASX: XJO) in the December rebalance.

Shaw & Partners is among the brokers giving this stock a buy rating.

The broker has a 12-month price target of $11.20 on Silex Systems shares.

The post 9 ASX All Ords shares upgraded to strong buy ratings for the new year appeared first on The Motley Fool Australia.

The post Here are the top 10 ASX 200 shares today appeared first on The Motley Fool Australia.

Orica held its annual general meeting on Tuesday, with managing director Sanjeev Gandhi bullish on the company's prospects for the year ahead.

As he told the meeting:

Building on the strong performance in 2025, we have started the 2026 financial year with strong momentum. Demand for blasting technology, specialty mining chemicals and digital solutions remains strong, and our disciplined approach to execution and capital allocation positions us to navigate inflationary pressures, energy costs and geopolitical uncertainty. Looking forward, Orica is well-positioned to continue to deliver profitable growth across all three business segments and create enduring value for our customers and shareholders.

Balance sheet management

On capital management, Mr Gandhi said that in 2025 the company had, for the first time in a decade, conducted a share buyback which was "substantially completed … and this program has been increased by up to an additional $100 million, demonstrating our ongoing commitment to delivering value for our shareholders''.

Mr Gandhi said the company's "disciplined approach" to capital management and prudent balance sheet was "structured to withstand volatility in the external environment''.

We continue to deliver our strategy in dynamic operating environments, where shifting market conditions and evolving societal expectations create new opportunities for innovation, adaptation and global growth— strengthening Orica's position and supporting long-term value creation for our customers and shareholders.

Share price gains on the cards

The analysts at RBC Capital markets said in a note to clients on Tuesday morning that company's musings at the AGM appeared to be "slightly more positive than the commentary provided at the FY2025 result on 13 November 2025 as the company stated that it had started the 2026 financial year with 'strong' momentum as opposed to the November characterisation of 'good' momentum''.

The RBC team went on to say:

The remainder of the language in relation to the 2026 outlook remains broadly consistent with that provided on November 13 and is consistent with our earnings forecasts. We retain our Outperform rating and $27.50 price target. Orica also reiterated that it is well-positioned to continue to deliver profitable growth across all three business segments.

If the Orica share price were to reach the RBC price target, it would mark a fresh 12-month high and represent a 16.3% increase from the current share price of $23.64.

Orica was valued at $11.1 billion at the close of trade on Monday.

The post Broker tips more than 15% upside for Orica shares after a "strong" start to the year appeared first on The Motley Fool Australia.

Will the market be able to bounce back from this on Tuesday? Here are five things to watch:

ASX 200 expected to fall again

The Australian share market looks set to fall again on Tuesday following a poor start to the week on Wall Street. According to the latest SPI futures, the ASX 200 is poised to open the day 15 points or 0.2% lower. In late trade in the United States, the Dow Jones is down 0.1%, the S&P 500 is 0.1% lower, and the Nasdaq has fallen 0.4%.

Oil prices drop

It could be a poor session for ASX 200 energy shares Karoon Energy Ltd (ASX: KAR) and Santos Ltd (ASX: STO) after oil prices fell overnight. According to Bloomberg, the WTI crude oil price is down 1% to US$56.86 a barrel and the Brent crude oil price is down 0.85% to US$60.60 a barrel. This was driven by optimism over a Russia-Ukraine peace deal after the latter agreed to scrap its NATO membership application.

Orica AGM

Eyes will be on Orica Ltd (ASX: ORI) shares on Tuesday when the commercial explosives company holds its annual general meeting. There's a chance the ASX 200 share will provide the market with a trading update ahead of the main event.

Gold price edges higher

ASX 200 gold shares Evolution Mining Ltd (ASX: EVN) and Ramelius Resources Ltd (ASX: RMS) could have a decent session on Tuesday after the gold price edged higher overnight. According to CNBC, the gold futures price is up 0.25% to US$4,339.2 an ounce. Traders were buying gold ahead of the release of US economic data.

Buy EOS shares

Electro Optic Systems Holdings Ltd (ASX: EOS) shares could be great value despite rising almost 400% this year. According to a note out of Bell Potter, this morning, its analysts have reiterated their buy rating on the space and defence company's shares with an improved price target of $9.00 (from $8.10). It said: "EOS is positioned as a market leader in C-UAS solutions and is leveraged to increasing budget allocations to C-UAS technologies. We see positive news flow over the next 6 months stemming from CUAS and RWS contract awards."

The post 5 things to watch on the ASX 200 on Tuesday appeared first on The Motley Fool Australia.

In 2025, it has seen its share price rise more than 40%. 

What's behind the success of this ASX 200 stock?

This rise has been driven by the company's strategic shift from being a pure explosives supplier to a broader, more diversified provider. 

The Motley Fool's Marc Van Dinther reported earlier this month that acquisitions in specialty chemicals businesses and the roll-out of digital blasting platforms have helped generate higher-margin, repeatable revenue rather than one-off explosives sales.

In its most recent financial results, the company reported its highest profit in 13 years. 

It also reported an EBIT of $992 million and strong growth across all segments. 

The company also paid out a record full year dividend of 57 cents, an increase of  21% from last year's 47 cents.

Macquarie's updated view

The team at Macquarie released a new report yesterday with updated guidance on this ASX 200 stock. 

One key takeaway from the report is the company's preparation for a strategy refresh (details expected in March) following positive early FY26 momentum.

Macquarie said Vik Bansal commences as Chairman post Dec 16 AGM who has a strong track record of cost out from his time as CEO of Boral (ASX: BLD).

Macquarie also highlighted that Orica could close the gap between itself and competitor Dyno Nobel (ASX: DNL). 

It said Dyno Nobel is in midst of its $300m transformation program; this is lifting margins with full benefits targeted in FY28. 

Dyno Nobel's EBIT margins are above Orica's at 13.4% (12.9% explosives) vs ORI's 12.0% in FY25a. 

In our view, an opportunity exists for ORI to close the margin gap to DNL through cost-out and mix benefit as higher margin Digital & SMC grows faster than Blasting. As a scenario, narrowing the gap by half over next 3-4 years would = c$100m of EBIT & a ~10% benefit to our FY28e/FY29e EPS.

Valuation

Macquarie said Orica shares are currently trading at 17.2× FY27 PE, a ~5% discount to the ASX100. 

It also said it is trading at a slight discount to competitor Dyno Nobel's 17.6x and it sees a positive earnings outlook for the ASX 200 stock coupled with a strong balance sheet.

Based on this guidance, Macquarie has an outperform rating on this ASX 200 stock. 

It also has a price target of $25.95. 

This indicates an upside of 10.85%. 

The post Macquarie tips double digit upside for this ASX 200 stock appeared first on The Motley Fool Australia.